Form 4: Pacira BioSciences COO Daryl Gaugler Reports Stock Transaction
SEC Form 4 Filing
Chief Operating Officer of Pacira BioSciences, Daryl Gaugler, reports a transaction involving common stock to cover tax withholding obligations.
Summary
- On June 3, 2024, Daryl Gaugler, the Chief Operating Officer of Pacira BioSciences, engaged in a transaction involving the company's common stock.
- A total of 2,754 shares were disposed of at a price of $30.89 per share to cover tax withholding obligations upon the vesting of a restricted stock unit award.
- Following the transaction, Gaugler directly owns 62,739.584 shares of Pacira BioSciences common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in company stock. This allows investors to track management's sentiment and actions regarding their company's equity.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of stock transaction |
| 06/05/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.